Page 1

Biopharmaceuticals Market Market Overview: In 2018, the global biopharmaceuticals market was valued at USD 237,250.8 million and is estimated at USD 388,997.3 million in 2024, a CAGR of 8.59%. Because of their ability to treat previously untreatable diseases, market growth is attributed to increasing acceptance for biopharmaceuticals, resulting in huge market demand for biopharmaceuticals.

Biopharmaceutical products give several advantages, such as extremely efficient and powerful action, fewer side effects, and the ability to effectively cure illnesses rather than simply treat the symptoms, which have considerably enhanced demand for biopharmaceutical products. Over the past decade, biopharmaceuticals have reduced the number of deaths caused by cancer and HIV / AIDS, leading to an increase in the adoption of biopharmaceuticals in the global market. Biopharmaceuticals have provided an alternative to medicines that were earlier less efficient and sometimes unsafe, allowing clinicians to tailor treatments to the particular medical issues that each patient experiences. Scope of the Report:

Biopharmaceutical refers to any biologically synthesized molecule used to treat or manage disorders for the scope of the report. Get a Free Sample Copy of this Report @ Key Trends in the Biopharmaceuticals Market: Monoclonal Antibodies are Expected to have the Largest Market Size: Monoclonal antibodies are thought to have the largest market size among the segments. This can be attributed with the help of monoclonal antibodies to the growing research. On the other hand, the recombinant enzymes segment is expected to show rapid growth during the forecast period. Monoclonal antibodies mAbs are used in cancer treatment areas. In developed countries, such as the United States and the United Kingdom, their use is becoming prevalent. The oncology mAb drugs are gaining momentum and increasing at an appropriate speed. The segment currently dominates the market and it is expected that the trend will be followed in the future. Due to their efficacy in the digestion of dietary proteins, recombinant enzymes such as Enterokinase are gaining attraction. Over the years, Enterokinase has generated 100 percent indigenous protein sequences. In latest years, this application has enhanced the marketplace for this specific enzyme. North America is Expected to Dominate the Biopharmaceuticals Market: North America is presently dominating the biopharmaceutical industry and its stronghold is anticipated to continue for a few more years. Asia-Pacific is anticipated to boost its market share in the future due to an rise in disease prevalence, such as diabetes and cancer, as well as the legislative framework that is viable for biopharmaceutical authorization in the region. In the North American region, the United States holds most of the market; this is due to the growing incidence of chronic diseases. Furthermore, there is an increase in health expenditure per capita in the nation, which is anticipated to boost over the forecast period due to the fall in the unemployment rate. Get More Information about this Report and TOC @

Competitive Landscape: The biopharmaceuticals market is extremely competitive and is made up of several significant players. In terms of market share, the market is presently dominated by few of the main players. However, mid-size to smaller companies are increasing their market presence with technological advancement and product innovation by introducing new products with lower prices. Companies such as Amgen Inc., Eli Lily & Company, Johnson & Johnson, and Pfizer Inc. have a substantial share of the biopharmaceuticals market.

TABLE OF CONTENT: CHAPTER 1 INTRODUCTION 1.1. Market Definition 1.2. Executive Summary 1.3. The Scope of the Study CHAPTER 2 RESEARCH METHODOLOGY 2.1. Secondary Research 2.2. Primary Research 2.3. Analytic Tools and Model 2.4. Economic Indicator 2.4.1. Base Year, Base Currency, Forecasting Period 2.5. Expert Validation 2.6. Study Timeline CHAPTER 3 MARKET ANALYSIS 3.1. Industry Value Chain Analysis 3.2. Porters Five Force Analysis 3.2.1. Bargaining Power of Buyers 3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes 3.2.4. Threats of New Entrants 3.2.5. Degree of Competition 3.3. PESTLE Analysis 3.3.1. Political 3.3.2. Economical 3.3.3. Social 3.3.4. Technological 3.3.5. Legal 3.3.6. Environmental 3.4. SWOT Analysis 3.4.1. Strengths 3.4.2. Weakness 3.4.3. Opportunities 3.4.4. Threats 3.5. Y-O-Y Analysis CHAPTER 4 MARKET DYNAMICS 4.1. Market Drivers 4.1.1. Growing Acceptance for Biopharmaceuticals 4.1.2. Ability of Biopharmaceuticals to Treat Previously Untreatable Diseases 4.1.3. Huge Market Demand 4.2. Market Restraints 4.2.1. Rising Demand for Affordable Biopharmaceuticals 4.2.2. High-end Manufacturing Requirements 4.2.3. Complicated and Cumbersome Regulatory Requirements 4 .3. Market Opportunities 4.4. Market Challenges CHAPTER 5 BIOPHARMACEUTICALS MARKET – BY PRODUCT TYPE 5.1. Monoclonal Antibodies 5.1.1. Anti Cancer Monoclonal Antibodies 5.1.2. Anti-inflammatory Monoclonal Antibodies 5.1.3. Other Monoclonal Antibodies 5.2. Recombinant Growth Factors 5.2.1. Erythropoietin 5.2.2. Granulocyte Colony Stimulating Factor 5.3. Purified Proteins 5.3.1. Leukemia Inhibitory Factor LIF 5.3.2. P53 Protein

5.3.3. P38 Protein 5.3.4. Other Purified Proteins 5.4. Recombinant Proteins 5.4.1. Serum Albumin 5.4.2. Amyloid Protein 5.4.3. Defensin 5.4.4. Transferrin 5.5. Recombinant Hormones 5.5.1. Recombinant Hormones 5.5.2. Recombinant Insulin 5.5.3. Other Recombinant Hormones 5.6. Vaccines 5.6.1. Recombinant Vaccines Cancer Vaccines Malaria Vaccines Ebola Vaccine Hepatitis-b Vaccine Tetanus Vaccine Diptheria Vaccine Cholera Vaccine Other Vaccines 5.6.2. Conventional Vaccines Polio Vaccine Pox Vaccine Other Conventional Vaccines 5.6.3. Recombinant Enzymes Enterokinase Cyclase Caspase Cathepsin 5.6.4. Cell and Gene Therapies Allogeneic Products Autologous Products Acellular Products 5.6.5. Other Product Types Blood Factors Other Product Types 5.7. Synthetic Immunomodulators

5.7.1. Cytokines, Interferones, Interleukins 5.7.2. Tumor Necrosis Factor TNF Enquire Now… @ CHAPTER 6 BIOPHARMACEUTICALS MARKET – BY THERAPEUTIC APPLICATION 6.1. Oncology 6.2. Inflammatory and Infectious Diseases 6.3. Autoimmune Disorders 6.4. Metabolic Disorders 6.5. Hormonal Disorders 6.6. Disease Prevention 6..7. Cardiovascular Diseases 6.8. Neurological Diseases 6.9. Other Diseases CHAPTER 7 BIOPHARMACEUTICALS MARKET – BY GEOGRAPHY 7.1. Introduction 7.2. North America 7.2.1. U.S. 7.2.2. Canada 7.2.3. Mexico 7.2.4. Costa Rica 7.3. South America 7.3.1. Brazil 7.3.2. Argentina 7.3.3. Chile 7.3.4. Columbia 7.3.5. Others 7.4. Europe 7.4.1. U.K. 7.4.2. Germany 7.4.3. France 7.4.4. Italy 7.4.5. Spain 7.4.6. Russia 7.4.7. Netherlands 7.4.8. Switzerland 7.4.9. Poland

7.4.10. Others 7.5. Asia-Pacific 7.5.1. China 7.5.2. Japan 7.5.3. India 7.5.4. South Korea 7.5.5. Australia & New Zealand 7.5.6. Malaysia 7.5.7. Singapore 7.5.8. Others 7.6. Middle East & Africa 7.6.1. UAE 7.6.2. Saudi Arabia 7.6.3. Iran 7.6.4. Iraq 7.6.5. Qatar 7.6.6. South Africa 7.6.7. Algeria 7.6.8. Morocco 7.6.9. Nigeria 7.6.10. Egypt 7.6.11. Others CHAPTER 8 BIOPHARMACEUTICALS MARKET – COMPANY PROFILES 8.1. Roche Holding AG 8.2. GlaxoSmithKline PLC 8.3. Pfizer Inc. 8.4. Novo Nordisk Inc. 8.5. Novartis AG 8.6. Johnson & Johnson 8.7. Eli Lily & Co. 8.8. Bristol-Myers Squibb Company 8.9. Amgen Inc. 8.10. Abbvie Inc. CHAPTER 9 BIOPHARMACEUTICALS MARKET – COMPETITIVE LANDSCAPE 9.1. Market Share Analysis 9.2. Strategies adopted by top companies 9.3. Mergers, Acquisitions, Collaborations & Agreements CHAPTER 10 MARKET INSIGHTS

10.1. Industry Experts Insights 10.2 Analysts Opinions 10.3. Investment Opportunities CHAPTER 11 APPENDIX 11.1. List of Tables 11.2. List of Figures About Us: Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe. We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available. Name: Jennifer Daniel Email-Id: US: +1-716-2260907 UK: +447441952057 Organization: Planet Market Reports

Profile for william joe

Biopharmaceuticals Market analysis and forecast  

In 2018, the global biopharmaceuticals market was valued at USD 237,250.8 million and is estimated at USD 388,997.3 million in 2024, a CAGR...

Biopharmaceuticals Market analysis and forecast  

In 2018, the global biopharmaceuticals market was valued at USD 237,250.8 million and is estimated at USD 388,997.3 million in 2024, a CAGR...

Profile for willjo936